TY - JOUR
T1 - Cardiac tachyarrhythmias and patient values and preferences for their management
T2 - The European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
AU - Lane, Deirdre A.
AU - Aguinaga, Luis
AU - Blomström-Lundqvist, Carina
AU - Boriani, Giuseppe
AU - Dan, Gheorge Andrei
AU - Hills, Mellanie True
AU - Hylek, Elaine M.
AU - Lahaye, Stephen A.
AU - Lip, Gregory Y.H.
AU - Lobban, Trudie
AU - Mandrola, John
AU - McCabe, Pamela J.
AU - Pedersen, Susanne S.
AU - Pisters, Ron
AU - Stewart, Simon
AU - Wood, Kathryn
AU - Potpara, Tatjana S.
AU - Gorenek, Bulent
AU - Conti, Jamie Beth
AU - Keegan, Roberto
AU - Power, Suzannah
AU - Hendriks, Jeroen
AU - Ritter, Philippe
AU - Calkins, Hugh
AU - Violi, Francesco
AU - Hurwitz, Jodie
PY - 2015/12
Y1 - 2015/12
N2 - Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are of-ten highly symptomatic and the psychological impact of the disease can be significant. Patients’ beliefs and knowledge about their health(and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients’ values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy.It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a TaskForce was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS),Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoa-mericana de Estimulacio ́n Cardı ́aca y Electrofisiologı ́a (SOLEACE),with the remit to comprehensively review the published evidenceavailable, to publish a joint consensus document on patient valuesand preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. Hence this unique consensus document focuses on patients, summarizing the available literature on patients’ experiences of living with various cardiac tachyarrhythmias and their treatment preferences,and identifies gaps in knowledge which will help to inform clinical practice and future research. The document will also summarize key points for discussions with patients during consultations regarding their condition, treatment options, disease trajectory, treatment goals, and outcomes. Finally, this document provides links to useful resources and patient advocacy groups and organizations and professional societies relevant to each group of cardiac tachyarrhythmias.
AB - Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are of-ten highly symptomatic and the psychological impact of the disease can be significant. Patients’ beliefs and knowledge about their health(and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients’ values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy.It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a TaskForce was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS),Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoa-mericana de Estimulacio ́n Cardı ́aca y Electrofisiologı ́a (SOLEACE),with the remit to comprehensively review the published evidenceavailable, to publish a joint consensus document on patient valuesand preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. Hence this unique consensus document focuses on patients, summarizing the available literature on patients’ experiences of living with various cardiac tachyarrhythmias and their treatment preferences,and identifies gaps in knowledge which will help to inform clinical practice and future research. The document will also summarize key points for discussions with patients during consultations regarding their condition, treatment options, disease trajectory, treatment goals, and outcomes. Finally, this document provides links to useful resources and patient advocacy groups and organizations and professional societies relevant to each group of cardiac tachyarrhythmias.
KW - Cardiac arrhythmia
KW - Patient education programme
KW - Patient's values
KW - Patient-reported outcomes
KW - patient-centred care
KW - Preferences
KW - Quality of life
KW - Shared decision-making
UR - http://www.scopus.com/inward/record.url?scp=84946493406&partnerID=8YFLogxK
U2 - 10.1093/europace/euv233
DO - 10.1093/europace/euv233
M3 - Article
C2 - 26108807
AN - SCOPUS:84946493406
VL - 17
SP - 1747
EP - 1769
JO - EUROPACE
JF - EUROPACE
SN - 1099-5129
IS - 12
ER -